CLINICAL_TRIALS trial_result · 2022-05-23

Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder [Phase 2]

A Phase 2 study evaluating the efficacy, safety, and tolerability of JNJ-42847922 in adults with insomnia has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Janssen Research & Development, LLC | Conditions: Insomnia Disorders | Phase 2 | Status: COMPLETED | Results posted: 2022-05-23